Естония - естонски - Ravimiamet

abiogen pharma s.p.a. - kolekaltsiferool - kõvakapsel - 1000rÜ 30tk

Естония - естонски - Ravimiamet

abiogen pharma s.p.a. - kolekaltsiferool - kõvakapsel - 25000rÜ 12tk

Естония - естонски - Ravimiamet

abiogen pharma s.p.a. - kolekaltsiferool - kõvakapsel - 6000rÜ 12tk

Европейски съюз - естонски - EMA (European Medicines Agency)

gilead sciences ireland uc - sacituzumab govitecan - breast neoplasms; triple negative breast neoplasms - antineoplastilised ained - trodelvy as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (mtnbc) who have received two or more prior systemic therapies, including at least one of them for advanced disease.

Естония - естонски - Ravimiamet

casen recordati s.l. - naatriumpikosulfaat+magneesiumoksiid+sidrunhape - suukaudse lahuse pulber kotikeses - 10mg+3,5g+10,97g 100tk; 10mg+3,5g+10,97g 500tk

Европейски съюз - естонски - EMA (European Medicines Agency)

samsung bioepis nl b.v. - eculizumab - hemoglobinuuria, paroksüsmaalne - immunosupressandid - epysqli is indicated in adults and children for the treatment of paroxysmal nocturnal haemoglobinuria (pnh). evidence of clinical benefit is demonstrated in patients with haemolysis with clinical symptom(s) indicative of high disease activity, regardless of transfusion history.

Естония - естонски - Ravimiamet

qilu pharma spain s.l. - piperatsilliin+tasobaktaam - infusioonilahuse pulber - 4g+0,5g 25tk; 4g+0,5g 5tk; 4g+0,5g 50tk; 4g+0,5g 12tk; 4g+0,5g 1tk; 4g+0,5g 10tk

Естония - естонски - Ravimiamet

ideal trade links uab - piperatsilliin+tasobaktaam - infusioonilahuse pulber - 4000mg+500mg 24tk; 4000mg+500mg 12tk

Европейски съюз - естонски - EMA (European Medicines Agency)

novartis europharm limited - brinsolamiidi, timolooli maleaat - glaucoma, open-angle; ocular hypertension - oftalmoloogilised vahendid - silmasisese rõhu (iop) vähenemine avatud nurga glaukoomi või okulaarse hüpertensiooniga täiskasvanud patsientidel, kellel monoteraapia ei võimalda iop vähenemist.

Европейски съюз - естонски - EMA (European Medicines Agency)

belpharma s.a. - tasonermiin - sarkoom - immunostimulants, - beromun on näidatud täiskasvanute lisandina, et operatsioon järgnevate eemaldamist kasvaja nii, et vältida või edasi lükata amputatsioon või palliatiivne olukord, irresectable pehmete kudede sarkoom, jäsemete, kasutatakse koos melphalan kaudu kerge hyperthermic isoleeritud jäseme perfusiooni (ilp).